U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne
Clinical trial NCT01706263 · COMPLETED
Trial details
- NCT number
- NCT01706263
- Sponsor
- Stiefel, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2009-11-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.